U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07651332) titled 'A Study of Probiotics in Patients With Acute Ischemic Stroke' on June 11.
Brief Summary: The primary objective of this study is to evaluate the effect of daily oral administration of the probiotic supplement OMNi-BiOTiC(R) SR-9 for 90 days, compared to placebo, on gut microbiome beta diversity in patients aged 60 years or older with acute ischemic stroke.
Study Start Date: Sept. 01, 2026
Study Type: INTERVENTIONAL
Condition:
Ischemic Stroke
Intervention:
DIETARY_SUPPLEMENT: probiotic supplement OMNi-BiOTiC(R) SR-9
Each sachet contains approximately 7.5 x 10^9 live bacteria. Administered orally twice daily.
OTHER: Matching Pl...